News & Media

SK life science

Welcome to the news and information center for SK Life Science, Inc. (SKLSI), a CNS-focused pharmaceutical company

Here you will find the latest announcements and contact information for SK life science.

For media inquiries, please contact .

Download corporate fact sheet >
Download epilepsy fact sheet >

General business

Strategic alliance and partnership opportunities

Media inquiries and PR

Grants and sponsorship requests

SK life science at a glance

  • Headquarters location

    PARAMUS, NJ

  • Year Established

    1993

  • Parent Company

    SK life science is a subsidiary of SK Biopharmaceuticals, Co., Ltd., and both are part of the SK Group

  • Number of employees

    100+ EMPLOYEES

  • Disease Category Focus

    CNS

  • Pipeline

    8 compounds under clinical development

Press releases

SK life science Provides Update on Recent Company Milestones and Accomplishments

Full release

SK life science to Showcase Scientific Data at the 2019 American Academy of Neurology Annual Meeting

Full release

SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe

Full release

SK life science announces FDA acceptance of NDA submission for cenobamate, an investigational antiepileptic drug

Full release

SK life science presents new data on its lead investigational compound, cenobamate, at the American Epilepsy Society 2018 Annual Meeting

Full release

SK life science honors Epilepsy Awareness Month with support for patients, advocates, caregivers, and healthcare providers

Full release

SK life science awards educational grant to J. Kiffin Penry Epilepsy Education Programs in support of neurology residents and epilepsy fellows

Full release

SK life science presents data on the investigational antiepileptic drug, cenobamate, at the American Academy of Neurology Annual Meeting 2018

Full release

SK life science to present data on cenobamate, an investigational antiepileptic compound, at ASCPT 2018 Annual Meeting

Full release

SK life science launches new corporate presence, expanded commercial operations in the United States.

Full release